Market Update (NYSE:MDT): Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

[Thomson Reuters ONE] – First Patients Successfully Treated in Study to Evaluate Next Generation Transcatheter Valve MINNEAPOLIS – Sept. 10, 2014 – Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in . . . → Read More: Market Update (NYSE:MDT): Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R Similar Articles: Stock Update (NYSE:MDT): Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S. Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2015